1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with malabaricone c in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (malabaricone c) | Trials (malabaricone c) | Recent Studies (post-2010) (malabaricone c) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 28 | 0 | 20 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | malabaricone c (IC50) |
|---|---|---|---|
| Acetylcholinesterase | Homo sapiens (human) | 1.94 | |
| Sialidase A | Streptococcus pneumoniae | 0.3 | |
| Cholinesterase | Equus caballus (horse) | 2.8 | |
| Phosphatidylcholine:ceramide cholinephosphotransferase 1 | Homo sapiens (human) | 2.5 | |
| Phosphatidylcholine:ceramide cholinephosphotransferase 2 | Homo sapiens (human) | 1.25 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, H; Kanzaki, K; Kawakami, Y; Maruoka, S; Miki, Y; Mori, Y; Murakami, M; Nagasaki, Y; Okamoto, K; Sawazumi, R; Suzuki-Yamamoto, T; Takahashi, Y; Tamenobu, A; Toda, K; Tsukayama, I; Yamamoto, K | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and malabaricone c
| Article | Year |
|---|---|
Malabaricone C derived from nutmeg inhibits arachidonate 5-lipoxygenase activity and ameliorates psoriasis-like skin inflammation in mice.
Topics: Animals; Arachidonate 5-Lipoxygenase; Inflammation; Leukotrienes; Mice; Myristica; Platelet Activating Factor; Psoriasis | 2022 |